North America Blood Group Typing Market

North America Blood Group Typing Market Size

The size of the North America blood group typing market was worth USD 1.28 billion in 2025. The market is anticipated to grow at a CAGR of 9.30% from 2026 to 2034 and be worth USD 2.85 billion by 2034 from USD 1.40 billion in 2026.

MARKET DRIVERS

Rising Transfusions and Demand for Accurate Molecular Typing

Classification of blood on the basis of absence and presence of antibodies or inherited antigenic substances on the surface of red blood cells is termed as blood group typing. These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending on the blood group system. Some of these antigens are present on the surface of other types of cells of various tissues. Several of these red blood cell surface antigens can stem from one allele and collectively form a blood group system.

The North America market for molecular blood grouping is increasing significantly. The market has a lot of potential due to a growth in the demand for blood transfusion. For the purpose of transfusion, donor blood compatibility with recipient patient is highly important. Therefore, before transfusion of blood, in order to check compatibility, blood samples are cross-matched with each other. Transfusion of blood is usually safe; however, alloimmunization can create a complication in the recipient. The alloimmunization can be dreadful in patients’ suffering from diseases like sickle cell anemia.

The molecular blood group typing is used to determine the presence of antigens in the red blood cells through testing. In general, A, B, and D (Rh) antigens are tested as part of standard procedure, followed by determination of other antigens if required. Reverse grouping confirms ABO blood group typing by detecting expected iso-agglutinins.

The varying use of blood typing and grouping test in research activities and transfusion procedures has upsurge the molecular blood typing, grouping and infectious disease nucleic acid testing market. Factors such as the increased government interventions and growing demand have increased the market for molecular blood typing, grouping, and infectious disease NAT.

MARKET RESTRAINTS

Logistical Barriers, High Costs, and Equipment Requirements

Restraining factors like administrative and logistical challenges, slow turnaround, high cost, the requirement of high-end equipment and inadequate information systems for handling the results. Owing to these facts, the market observes a rise in the demand for molecular typing tests. The adoption of molecular testing in blood transfusion procedures has mitigated the challenges faced to a significant extent. 

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

The consumables segment is expected to grow at the highest CAGR during the forecast period. The sudden rise in blood donation rates is another key factor driving the growth of this segment.

By Test Type Insights

The antibody screening segment is projected to witness the highest CAGR in this market segment in the coming years due to the increasing prevalence of chronic disorders and growing demand for the early diagnosis of diseases. 

By Technique Insights

The PCR-based and microarray techniques segment accounted for the largest share of this market segment and is further expected to grow at the highest CAGR during the forecast period due to the rising prevalence of chronic diseases and increasing R&D activities focused on understanding the molecular basis of blood and antibody-antigen interactions.

By End User Insights

The hospitals end-user segment is expected to grow at the highest CAGR during the forecast period owing to an increase in the awareness among people regarding blood donations and its importance, rising number of blood donations, and growing requirement of blood in surgical treatments.

COUNTRY LEVEL ANALYSIS

North America occupies the largest market share followed by Europe. The United States has been the major market across the world. Factors such as advanced technology, research, and development activities have boosted the North America market.

KEY MARKET PLAYERS

The market is dominated by companies like Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.

MARKET SEGMENTATION

This Asia Pacific blood group typing market research report is segmented and sub-segmented into the following categories.

By Product

• Consumables

  • Anti-human globulin reagents

  • Red blood cells reagents

  • Antisera reagents

  • Blood bank saline

• Instruments

• Services

By Test Type

• Prestige ABO

• Antigen

• Antibody Screening

• Cross Matching

• HLA

By Technique

• Assay

• PCR

• Microarray

• Massively Parallel Sequencing

By End User

• Clinical Laboratories

• Blood Banks

• Hospitals

• Other End Users

By Country

• United States
• Canada
• Mexico
• Rest of North America